| 000 | 01551 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513094632.0 | ||
| 264 | 0 | _c19960919 | |
| 008 | 199609s 0 0 eng d | ||
| 022 | _a0148-396X | ||
| 024 | 7 |
_a10.1097/00006123-199601000-00028 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZimmermann, M | |
| 245 | 0 | 0 |
_aPrevention of cerebral vasospasm after experimental subarachnoid hemorrhage by RO 47-0203, a newly developed orally active endothelin receptor antagonist. _h[electronic resource] |
| 260 |
_bNeurosurgery _cJan 1996 |
||
| 300 |
_a115-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBasilar Artery _xdiagnostic imaging |
| 650 | 0 | 4 | _aBosentan |
| 650 | 0 | 4 |
_aCerebral Angiography _xdrug effects |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aEndothelin Receptor Antagonists |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aIschemic Attack, Transient _xdiagnostic imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aReceptors, Endothelin _xphysiology |
| 650 | 0 | 4 |
_aSubarachnoid Hemorrhage _xcomplications |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacokinetics |
| 650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
| 700 | 1 | _aSeifert, V | |
| 700 | 1 | _aLöffler, B M | |
| 700 | 1 | _aStolke, D | |
| 700 | 1 | _aStenzel, W | |
| 773 | 0 |
_tNeurosurgery _gvol. 38 _gno. 1 _gp. 115-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00006123-199601000-00028 _zAvailable from publisher's website |
| 999 |
_c8744972 _d8744972 |
||